A First-in-Human Study to Assess Single and Multiple Doses of NXC736 in Healthy Participants
Clinical trial NCT05079425 · COMPLETED
Trial details
- NCT number
- NCT05079425
- Sponsor
- NEXTGEN Bioscience
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2022-11-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.